1-5 of 5
Ioannis Ntanasis-Stathopoulos
Close
Sort by
Journal Articles

Determination of MYD88 L265P mutation fraction in IgM monoclonal gammopathies

Tina Bagratuni, Athina Markou, Dimitrios Patseas, Nefeli Mavrianou-Koutsoukou, Foteini Aktypi, Christine Ivy Liacos, Aimilia D. Sklirou, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ioannis P. Trougakos, Evi Lianidou, Evangelos Terpos, Efstathios Kastritis, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2022) 6 (1): 189–199.
https://doi.org/10.1182/bloodadvances.2021005354
Published: 2022
Includes: Supplemental data
Journal Articles

Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study

Clinical Trials & Observations
Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4398–4405.
https://doi.org/10.1182/bloodadvances.2021005444
Published: 2021
Journal Articles

Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasone

Clinical Trials & Observations
Efstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, Nikolaos Kanellias, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios C. Ziogas, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Ioanna Dialoupi, Stavroula Giannouli, Panagiotis Tsirigotis, Sossana Delimpasi, Despina Mparmparousi, Mairylin Spyropoulou-Vlachou, Aikaterini Xirokosta, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4095–4103.
https://doi.org/10.1182/bloodadvances.2019000539
Published: 2019
Journal Articles

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Maria Roussou, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Kimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis-Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Aristea-Maria Papanota, Harikleia Gakiopoulou, Erasmia Psimenou, Maria Irini Tselegkidi, Ourania Tsitsilonis, Ioannis Kostopoulos, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3002–3009.
https://doi.org/10.1182/bloodadvances.2019000147
Published: 2019
Includes: Supplemental data
Journal Articles

Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial

Clinical Trials & Observations
Ersi Voskaridou, Ioannis Ntanasis-Stathopoulos, Athanasios Papaefstathiou, Dimitrios Christoulas, Maria Dimopoulou, Konstantina Repa, Athanasios Papatheodorou, Melpomeni Peppa, Evangelos Terpos
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2837–2847.
https://doi.org/10.1182/bloodadvances.2018023085
Published: 2018
Includes: Supplemental data